UK markets open in 7 hours 31 minutes
  • NIKKEI 225

    +279.36 (+0.71%)

    -25.41 (-0.15%)

    +0.10 (+0.13%)

    -2.70 (-0.13%)
  • DOW

    +47.37 (+0.12%)
  • Bitcoin GBP

    +20.16 (+0.04%)
  • CMC Crypto 200

    0.00 (0.00%)
  • NASDAQ Composite

    +144.18 (+0.90%)
  • UK FTSE All Share

    +3.64 (+0.09%)

Global Aesthetic Injectables Market Set to Expand: Industry Insights and Forecasts to 2033 Featuring AbbVie, Galderma, Merz Pharma, Huadong Medicine, and Teoxane

Company Logo
Company Logo

Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Aesthetic Injectables Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033" report has been added to's offering.

The Aesthetic Injectables market is poised for continued growth, according to this comprehensive market analysis. This detailed research provides insights into market trends, industry developments, and the projected impact of COVID-19 beyond 2020. This market, involving minimally invasive procedures aimed at enhancing facial aesthetics, has seen a surge in demand in recent years and is forecasted to grow significantly through 2033.

The report offers a granular examination of the Aesthetic Injectables market, touching on key segments, current and emerging market players, and pivotal changes within the regulatory landscape that could shape future markets. Insights include detailed procedure volumes, unit sales, average selling prices, and market valuations segmented by country and region.

The report's key inclusions are:

  • Detailed SWOT analysis of the Aesthetic Injectables market.

  • Competitive dynamics and industry trends.

  • Comprehensive breakdown of global, regional, and country-level market trends.

  • Overviews of healthcare systems, reimbursement policies, and medtech regulatory environments across different regions.

Through its robust methodologies, which integrate demand and supply-side primary sources including Key Opinion Leaders and real-world data points, the report addresses the need for a thorough understanding of the Aesthetic Injectables market.

Market Expansion Driven by Procedure Advancements and Aesthetic Trends

With a burgeoning aesthetic consciousness and the increasing preference for non-invasive procedures, aesthetic injectables have become a quintessential offering in cosmetic clinics globally. The updated findings reflect a diverse array of injectables gaining traction among consumers seeking rejuvenation without prolonged downtime.

Stakeholders in the healthcare industry including CMO executives, sourcing and procurement specialists, and private equity investors will find this report invaluable for making informed decisions. The wealth of data offered not only underlines market dynamics but also aligns with strategic planning and investment priorities.

As aesthetic preferences continue to evolve and the push for non-surgical interventions strengthens, this report will serve as an essential resource for those looking to align with market trends, gauge emerging opportunities, and strategize for future market developments.

The inclusion of a strategic analysis of the competitive landscape, coupled with a forward-looking perspective, ensures that the report serves as a compass for navigating the intricacies of the Aesthetic Injectables market.

A selection of companies mentioned in this report includes:

  • AbbVie Inc

  • Galderma SA

  • Merz Pharma GmbH & Co KgaA

  • Huadong Medicine Co Ltd

  • Teoxane SA

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: Laura Wood,Senior Press Manager For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900